Home The López-Belmonte family increase their interest in ROVI to 63.1%

The López-Belmonte family increase their interest in ROVI to 63.1%

Find out more …

FAQs
News
Contact

Mon, 27/05/2019 - 12:15

Descargar noticia

Download PDF
 

Comments

Add new comment

More information about text formats

Comment User

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Related News
30/07/2019
First half 2019 results presentation
30/07/2019
First half 2019 results press release
05/07/2019
ROVI announces completion of the Clinical Trial Program that will support the application for marketing authorization for Doria®